SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is generating significant community conversation ahead of its upcoming earnings call, driven by recent military contract news and growing institutional interest in the defense drone sector. Investors are actively debating the company's ability to convert its active project pipeline into tangible revenue as the firm expands its manufacturing footprint for maritime and aerial autonomous systems.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme selling pressure and significant analyst downgrades following a weak revenue outlook and concerns over structural competition in the ad-tech sector. Investors are actively debating whether the stock is a deep-value opportunity at current levels or a permanent casualty of management's poor execution and loss of market leadership.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending following positive Phase 2 clinical results for its ABCL635 menopause treatment, which successfully met primary endpoints for efficacy and safety. Community discourse is highly polarized between long-term investors highlighting the firm's royalty-rich pipeline and AI-driven antibody platform, and traders focusing on high short interest and aggressive short-term price volatility.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing high volatility as investors closely monitor Federal Reserve interest rate policy and geopolitical headlines, with the community actively debating whether recent price action signifies a long-term breakout or a temporary squeeze. Sentiment remains polarized between those accumulating physical silver as a hedge against fiat currency devaluation and skeptical traders who view recent rallies as potential bull traps within a challenging macroeconomic environment.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is trending as investors bet on its long-term growth in the cybersecurity and AI-driven data resilience sector, with community members actively discussing its potential for significant upside despite recent volatility. The stock is currently a focal point for those monitoring the rotation from semiconductors back into software and cloud-based infrastructure leaders.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is experiencing significant investor focus as the broader optical networking and photonics sector faces intense volatility, driven by shifting hyperscaler infrastructure demands and speculation around supply chain security. The community remains deeply engaged in analyzing the long-term impact of artificial intelligence buildouts, with active debates centered on production capacity constraints, supply chain shifts, and whether current price corrections represent structural headwinds or attractive entry points for the next phase of the AI infrastructure cycle.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is capturing investor attention following a mixed earnings report that beat revenue expectations, alongside the authorization of a significant $3 billion share buyback program. The community is actively debating the strategic merits of the company's planned North American asset spinoff and IPO, while weighing potential growth from gold and copper production against concerns regarding management execution and mining operational costs.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is facing high volatility and intense community debate as investors react to a significant strategic acquisition of three Boeing subsidiaries and a major equity stake taken by Boeing. While bulls are highlighting these developments as a transformative shift toward defense and autonomous flight technology, critics are pointing to ongoing share dilution and skepticism over the company's timeline for piloted transition.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors aggressively await phase 3 IZAR-1 trial results in psoriatic arthritis, with sentiment split between concerns over the CEO's 'about a month' timeline being exceeded and optimism that the data will validate a best-in-class profile. Community discussions focus on the potential for a transformative buyout or breakthrough designation, while technical traders closely monitor support levels amid significant institutional ownership.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle is experiencing significant market volatility driven by investor reactions to recent food safety headlines and broader sector-wide concerns regarding lettuce supplies. While some investors are utilizing the price dips as a buying opportunity based on strong historical fundamentals and expansion efforts, others remain cautious, debating whether current price levels represent a bottom or a continued downward trend.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

H.C. Wainwright⬆️ $IMMX&#39;s PT to $25, reiterated Buy and said -- For 2Q26, Immix reported a net loss of $0.18 per share vs. our prior estimate of a net loss of $0.15 per share. 
$PRTA $JNJ - GMAB AZN ABBV REGN 
H.C. Wainwright added—R&amp;D and SG&amp;A expenses were $5.3M and $7.1M respectively, vs. our prior estimates of $6.2M and $4.9M. We now project a full-year 2026 net loss of $0.72 per share vs. our prior net loss estimate of $0.62 per share. 
 
Immix ended 2Q26 with ~$234.2M in cash—providing an operational runway extending into mid-2027, in our view. 
 
After advancing our discounted cash flow (DCF)-based valuation and taking into account ex-U.S. sales from NXC-201, we reiterate our Buy rating and raise our 12-month price target to $25 from the prior $20 per share.

Fosco Sinibaldi

Jimmy Norton

BofA🏁 $IMMX and said: We initiate coverage of IMMX with a Buy rating and $27 PO. 
$PRTA $JNJ - GMAB ABBV REGN AZN 
BofA added: 
IMMX is developing NXC201 for AL amyloidosis, a rare disease with damaged vital organs and no approved treatments. 
 
Early data of NXC-201 shows ~95% complete response and rapid minimal residual disease in relapsed/refractory (r/r) AL amyloidosis. The safety profile was favorable for patients facing potential organ failure with no observed neurotoxicity. 
 
Updated phase 2 data is expected in late September, and 1-year follow-up data is expected in 1Q27 to support a potential BLA submission in 1H27. 
 
If approved, we think a clinical profile with deep and rapid response and tolerability could be key for adoption.

StockTwits Web

Immix Biopharma Inc

Prothena Corporation plc

Johnson & Johnson

Quantumup

's PT to $25, reiterated Buy and said -- For 2Q26, Immix reported a net loss of $0.18 per share vs. our prior estimate of a net loss of $0.15 per share. 


 - GMAB AZN ABBV REGN 
H.C. Wainwright added—R&D and SG&A expenses were $5.3M and $7.1M respectively, vs. our prior estimates of $6.2M and $4.9M. We now project a full-year 2026 net loss of $0.72 per share vs. our prior net loss estimate of $0.62 per share. 
 
Immix ended 2Q26 with ~$234.2M in cash—providing an operational runway extending into mid-2027, in our view. 
 
After advancing our discounted cash flow (DCF)-based valuation and taking into account ex-U.S. sales from NXC-201, we reiterate our Buy rating and raise our 12-month price target to $25 from the prior $20 per share.

@Quantumup $234 million cash should provide for operations into 2030. They made a mistake by projecting cash runway into mid 2027.

Mike Ma

StockTwits for iOS

 $234 million cash should provide for operations into 2030. They made a mistake by projecting cash runway into mid 2027.